Table 1 Prioritized ASD candidate genes

From: Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders

Gene

ASD.LGD

Seq.Quality

MIS.sig

CLIN.sig

MIP-targets

FMRP/RBFOX

RVIS%

pLI score

ATP1A1

1SP

validated

Yes

Both

5.00

1.00

CUX2

1SG

highConf

Yes

F

9.20

1.00

DSCAML1

1SP

validated

Yes

F

0.67

1.00

ELAVL2

1FS

validated

Yes

R

15.85

0.96

FAM91A1

1SG

validated

Yes

F

21.65

0.88

FBXW11

1SG

validated

Yes

R

20.08

1.00

RAPGEF4

1SP

highConf

Yes

Both

9.59

1.00

SMARCE1

1SP

highConf

Y(LGD)

Yes

R

23.48

1.00

SPTBN1

1SG

validated

Yes

F

0.17

1.00

TANC2

1SG

validated

Yes

Both

0.37

1.00

UBAP2L

1FS

highConf

Yes

F

3.33

1.00

UBR3

1FS

validated

Yes

Both

-

1.00

UBR5

1FS

highConf

Yes

Both

0.21

1.00

ZNF462

1FS

highConf

Y(LGD)

Yes

F

1.09

1.00

BRSK2

1SP

highConf

Both

4.95

0.89

DST

1FS

validated

Both

0.28

1.00

EP400

1FS

highConf

Both

7.32

1.00

GRIN2B

1FS,1SG,1SP

validated

Y

Y(LGD,MIS)

Both

1.28

1.00

NBEA

1SG

validated

Both

1.16

1.00

NCKAP1

1FS,1SG

validated

Both

3.85

1.00

NRXN1

1SG

validated

Both

1.78

1.00

SKI

1SG

highConf

Both

11.79

0.97

SPAG9

1FS

validated

Both

14.41

1.00

TRIM37

1SP

highConf

Both

5.31

1.00

BAI1

1SG

validated

F

1.00

BIRC6

1SG

highConf

F

0.07

1.00

CIC

1SG

validated

Y(LGD)

F

0.83

1.00

DIP2A

1SG,1FS

validated

F

8.68

1.00

DIP2C

1FS

validated

F

0.61

1.00

DOT1L

1SG

validated

F

2.18

1.00

KDM4B

1SG

highConf

F

13.00

1.00

KIAA0100

1SG

validated

F

2.12

0.92

KIAA2018

1SG

highConf

F

1.00

NF1

1SG

validated

Y(LGD)

F

0.39

1.00

RALGAPB

1FS

highConf

F

3.00

1.00

RELN

1SG

highConf

F

5.17

1.00

SHANK2

1FS

validated

F

2.03

1.00

SMARCC2

1SP

validated

F

8.51

1.00

STXBP5

1FS

highConf

F

4.70

1.00

TRIO

1FS

highConf

Y

F

0.57

1.00

BAZ2B

1FS

validated

R

13.09

1.00

BRWD1

1FS

validated

R

10.52

1.00

CSDE1

1SG

validated

R

6.18

1.00

CUL1

1SP

highConf

R

9.85

1.00

ERBB2IP

1SP

highConf

R

1.00

GABRB3

1FS

highConf

Y

 

R

25.36

1.00

GGNBP2

1SG

highConf

R

27.26

1.00

GRIA2

1SG

highConf

R

10.77

1.00

HECTD1

1FS

validated

R

0.45

1.00

MPP6

1SP

validated

R

26.90

0.99

NFIA

1SG

validated

R

18.59

1.00

NFIB

1SP

validated

R

16.62

0.98

PCSK2

1FS

validated

R

19.29

1.00

PRPF40A

1SP

highConf

R

8.28

0.88

RANBP2

1FS

highConf

R

1.77

1.00

UNC79

1FS

validated

R

1.27

1.00

XKR6

1SG

validated

R

16.93

1.00

YTHDC1

1FS

validated

R

18.25

1.00

  1. Notes: ASD.LGD represents LGD numbers and types in 3953 ASD patients from SSC and ASC cohorts. SG stopgain, FS frameshift, SP splice site. MIS.sig represents genome-wide significance for the de novo missense mutations in this gene based on the 10,927 NDD patients9. CLIN.sig represents whether there are clinical case-series reports for likely gene-disrupting (LGD) or missense (MIS) mutations of the specific genes